Viela Bio

Investors/Media

Press Release

Viela Bio Announces Data Presentations at the 8th Joint ACTRIMS-ECTRIMS Meeting, MS Virtual 2020

GAITHERSBURG, Md., Sept. 03, 2020 (GLOBE NEWSWIRE) -- Viela Bio (Nasdaq:VIE), a biotechnology company dedicated to the discovery, development and commercialization of novel treatments for autoimmune and severe inflammatory diseases, today announced that four abstracts have been accepted for presentation, including a late-breaker, at the upcoming 8th Joint Congress of the American Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) and European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS). The congress will be held virtually on September 11-13, 2020 with an Encore event featuring late-breaker and COVID-19 presentations on September 26, 2020.

Poster Presentations:
Title: AQP4-IgG seronegative patients in the N-MOmentum trial of inebilizumab in neuromyelitis optica spectrum disorder (P0189)
Date: Friday, September 11, 2020
Time: 8:00 AM EDT

Title: Serum neurofilament light chain levels (sNfL) correlate with attack-related disability in neuromyelitis optica (P0155)
Date: Friday, September 11, 2020
Time: 8:00 AM EDT

Title: Quiescent MRI activity in NMOSD: results from the N-MOmentum randomized placebo-
controlled trial (P0229)
Date: Friday, September 11, 2020
Time: 8:00 AM EDT

Late-Breaker Presentation:
Title: Pharmacodynamic modeling and exposure-response assessment of inebilizumab in subjects with neuromyelitis optica spectrum disorders (LB1239)
Date: Saturday, September 26, 2020
Time: 8:00 AM EDT

About Viela Bio

Viela Bio, headquartered in Gaithersburg, Maryland, is a biotechnology company dedicated to the discovery, development and commercialization of novel treatments for autoimmune and severe inflammatory diseases. For more information, please visit www.vielabio.com.

Source: Viela Bio 

Contacts:

Investors:
Solebury Trout
Chad Rubin
646-378-2947
crubin@soleburytrout.com 

Media:
Solebury Trout
Amy Bonanno
914-450-0349
abonanno@soleburytrout.com


vielabio-logo-blue (2).png

Source: Viela Bio

Shareholder Tools